- AdventHealth Research Institute
A new study reveals that people newly diagnosed with Type 2 diabetes face a significantly higher risk of developing aggressive cancers—including those of the liver, pancreas, and colon.
While obesity has long been linked to these cancers, the research suggests Type 2 diabetes itself may be an independent driver of cancer risk. The findings, presented at the 2025 European Congress on Obesity, analyzed data from over 23,000 people in the U.K. Biobank with new-onset Type 2 diabetes and compared them to more than 71,000 non-diabetic individuals of similar age, sex, and weight.
Over five years, cancer risk was clearly higher in the diabetes group:
- Liver cancer risk was nearly 4 times higher in men and 5 times higher in women.
- Pancreatic cancer risk rose 74% in men, nearly doubled in women.
- Colorectal cancer risk increased by more than 25% in both groups.
Lead author Owen Tipping from the University of Manchester said the link may stem from factors like inflammation, insulin resistance, or gut microbiome changes—beyond just excess weight.
Experts say more research is needed but agree the findings highlight the importance of early detection, healthy lifestyle changes, and ongoing monitoring. “This isn’t a reason to panic,” said oncologist Dr. Jack Jacoub. “It’s a reason to take action—through diet, exercise, and good blood sugar control.”
The takeaway? Type 2 diabetes may do more than disrupt blood sugar—it could quietly raise your cancer risk too.
Recent News
Clinical Trial Evidence on Diet and Type 1 Diabetes Outcomes
A new systematic review of clinical trials has found that no single dietary pattern consistently improves blood sugar control or weight management in youth and adults living with type 1 diabetes.
How Diet Shapes Gut Microbes and Energy Absorption
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity.
AdventHealth Neuroscience Institute Launches NIH-Funded THRIVE Trial
AdventHealth Neuroscience Institute has launched THRIVE, an NIH-funded clinical trial led by Lauren Oberlin, PhD, geriatric neuropsychologist and neuroscience researcher.
AdventHealth Tampa Enrolls First Patient in the Tectonic CAD IVL Trial
On September 19, 2025, AdventHealth Tampa successfully enrolled its first patient in the Tectonic CAD Intravascular Lithotripsy (IVL) Trial, led by Dr. Mahmaljy and his team.
MANIFEST US Study Presented as a Late-Breaking Clinical Trial at AHA
The cardiovascular team is excited to highlight the MANIFEST US study, which was presented on November 10th as a Late-Breaking Clinical Trial at the American Heart Association (AHA) Scientific...
Nourishing Your Gut: Dr. Karen Corbin on the Power of Fiber
Dr. Karen Corbin, associate investigator at the AdventHealth Translational Research Institute for Metabolism and Diabetes in Orlando, emphasizes the essential role of diet in maintaining a healthy gut...
Southeast Region – Redmond Campus: AdventHealth Recognized as Top Enroller Nationally for the CARVTOP-ICD Trial
AdventHealth Research Institute (AHRI) is proud to announce that the Southeast Region’s Redmond Campus has been recognized as the top enrolling site nationally for the CARVTOP-ICD trial.
Stiff Arteries Linked to Early Memory Decline: New Findings by Dr. Amani Norling
Amani Norling, PhD a post-doctoral fellow at the AdventHealth Neuroscience institute, has published a notable paper titled “Arterial stiffness moderates the link between NfL and cognition: The IGNITE...
First BrioVAD Implant Successfully Completed
On September 24, the Transplant team successfully implanted the first BrioVAD device at AdventHealth, a major milestone in the ongoing INNOVATE 2254936 Vidic trial.
Advancing T1D Science: New TRI Publications
Researchers at the AdventHealth Translational Research Institute continue to drive meaningful progress in Type 1 diabetes—work that is being recognized not just in Central Florida, but throughout the...
The T1D Daily Reset: Small Habits With Big Impact
As we head into 2026, many people living with Type 1 diabetes are looking for ways to reset their routines and start the year feeling more balanced and in control.
The Next Frontier: Preventing Type 1 Diabetes Before It Starts
Recent research led by AdventHealth’s Translational Research Institute and others reveals that Type 1 diabetes develops gradually and can now be detected early through blood tests, opening the door to...